Anticorps Recombinant de lapin anti-CTLA-4/CD152

CTLA-4/CD152 Recombinant Antibody for FC

Hôte / Isotype

Lapin / IgG

Réactivité testée

souris

Applications

FC

Conjugaison

APC Fluorescent Dye

CloneNo.

241100B8

N° de cat : APC-FcA98147

Synonymes

Ctla4, Cd152, Ctla 4, Ly 56



Applications testées

Résultats positifs en cytométrieCon A treated mouse splenocytes,

Dilution recommandée

ApplicationDilution
This reagent has been tested for flow cytometric analysis. It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Informations sur le produit

APC-FcA98147 cible CTLA-4/CD152 dans les applications de FC et montre une réactivité avec des échantillons souris

Réactivité souris
Hôte / Isotype Lapin / IgG
Clonalité Recombinant
Type Anticorps
Immunogène CTLA-4/CD152 Protéine recombinante Eg0632
Nom complet cytotoxic T-lymphocyte-associated protein 4
Masse moléculaire calculée25 kDa
Numéro d’acquisition GenBankNM_009843.4
Symbole du gène CTLA-4
Identification du gène (NCBI) 12477
Conjugaison APC Fluorescent Dye
Excitation/Emission maxima wavelengths650 nm / 660 nm
Forme Liquide
Méthode de purification Purification par protéine A
Tampon de stockage PBS with 0.09% sodium azide and 0.5% BSA
Conditions de stockageStore at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

Informations générales

CTLA-4, also known as CD152, belonging to the immunoglobulin superfamily, is primarily found on activated T cells and regulatory T cells (Tregs). CTLA-4 is closely related to the T-cell costimulatory CD28, and both molecules bind to B7-1 and B7-2 on antigen-presenting cells. CTLA-4 acts as a negative regulatory molecule of T-cell responses. Besides the full-length transmembrane form, CTLA-4 also exists in a truncated soluble form (sCTLA-4).

Protocole

Product Specific Protocols
FC protocol for APC CTLA-4/CD152 antibody APC-FcA98147Download protocol
Standard Protocols
Click here to view our Standard Protocols
{{ptg:RelatedPrimaryAntibodies}}